Spatiotemporal analysis of psychoactive drug consumption in Brazil during the COVID-19 pandemic

The COVID-19 pandemic had a significant impact on Brazil, although its effects were not homogeneous across the country. Socioeconomic disparities may influence epidemiological patterns during health emergencies, which impact population mental health. This study aimed to analyze the consumption of psychoactive medicines during the COVID-19 pandemic in Brazil and to characterize its spatiotemporal dynamics, identifying associated social, economic, and demographic factors. We used publicly available retail pharmacies dispensing data from January 2018 to September 2021 across Brazil's municipalities. A statistical model was developed based on indicators of infrastructure, human capital, and labor and income. Generalized additive models were used to characterize the spatiotemporal distribution of drug consumption. In September 2021, average consumption in municipalities reporting COVID-19-related deaths was 22% higher than in municipalities with no reported deaths. Among the most frequently consumed medicines during the study period, second-generation antidepressants were predominant. Life expectancy, employment and education showed positive linear associations with consumption, whereas inadequate water supply and sanitation were inversely associated. Municipality income was positively associated with average consumption of psychoactive medicines, but those with a very high-income development index showed more complex dynamics. Our results suggest that COVID-19 mortality was associated with psychotropic medicines consumption and indicate the need to address socioeconomic vulnerability as a key component of public health emergency response. The COVID-19 pandemic had a significant impact on Brazil, although its effects were not homogeneous across the country. Socioeconomic disparities may influence epidemiological patterns during health emergencies, impacting population mental health. This study aimed to analyze the consumption of psychoactive medicines during the COVID-19 pandemic in Brazil and to characterize its spatiotemporal dynamics, identifying associated social, economic, and demographic factors. We used publicly available data from retail pharmacy dispensing from January 2018 to September 2021 across Brazilian municipalities. A statistical model was developed based on indicators of infrastructure, human capital, labor, and income. Generalized additive models were used to characterize the spatiotemporal distribution of drug consumption. In September 2021, average consumption in municipalities reporting COVID-19-related deaths was 22% higher than in municipalities with no reported deaths. Among the most frequently consumed medicines during the study period, second-generation antidepressants were predominant. Life expectancy, employment, and education showed positive linear associations with consumption, whereas inadequate water supply and sanitation were inversely associated. Municipality income was positively associated with the average consumption of psychoactive medicines, but those with a very high human development index for income showed more complex dynamics. Our results suggest that COVID-19 mortality was associated with psychotropic medicine consumption and indicate the need to address socioeconomic vulnerability as a key component of public health emergency responses.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-05-11
DOI
https://doi.org/10.1371/journal.pone.0343552
Primary Topic
COVID-19 and Mental Health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Spatiotemporal analysis of psychoactive drug consumption in Brazil during the COVID-19 pandemic

Rafael Santos Erbisti, Elaine Silva Miranda, Branca Grinberg-Weller, Evani Leite de Freitas et al.
PLoS ONE
COVID-19 and Mental Health
article

Spatiotemporal analysis of psychoactive drug consumption in Brazil during the COVID-19 pandemic

Rafael Santos Erbisti, Elaine Silva Miranda, Branca Grinberg-Weller, Evani Leite de Freitas, Daniel Claudiano Cabral Pinto
article en

Abstract

The COVID-19 pandemic had a significant impact on Brazil, although its effects were not homogeneous across the country. Socioeconomic disparities may influence epidemiological patterns during health emergencies, which impact population mental health. This study aimed to analyze the consumption of psychoactive medicines during the COVID-19 pandemic in Brazil and to characterize its spatiotemporal dynamics, identifying associated social, economic, and demographic factors. We used publicly available retail pharmacies dispensing data from January 2018 to September 2021 across Brazil's municipalities. A statistical model was developed based on indicators of infrastructure, human capital, and labor and income. Generalized additive models were used to characterize the spatiotemporal distribution of drug consumption. In September 2021, average consumption in municipalities reporting COVID-19-related deaths was 22% higher than in municipalities with no reported deaths. Among the most frequently consumed medicines during the study period, second-generation antidepressants were predominant. Life expectancy, employment and education showed positive linear associations with consumption, whereas inadequate water supply and sanitation were inversely associated. Municipality income was positively associated with average consumption of psychoactive medicines, but those with a very high-income development index showed more complex dynamics. Our results suggest that COVID-19 mortality was associated with psychotropic medicines consumption and indicate the need to address socioeconomic vulnerability as a key component of public health emergency response. The COVID-19 pandemic had a significant impact on Brazil, although its effects were not homogeneous across the country. Socioeconomic disparities may influence epidemiological patterns during health emergencies, impacting population mental health. This study aimed to analyze the consumption of psychoactive medicines during the COVID-19 pandemic in Brazil and to characterize its spatiotemporal dynamics, identifying associated social, economic, and demographic factors. We used publicly available data from retail pharmacy dispensing from January 2018 to September 2021 across Brazilian municipalities. A statistical model was developed based on indicators of infrastructure, human capital, labor, and income. Generalized additive models were used to characterize the spatiotemporal distribution of drug consumption. In September 2021, average consumption in municipalities reporting COVID-19-related deaths was 22% higher than in municipalities with no reported deaths. Among the most frequently consumed medicines during the study period, second-generation antidepressants were predominant. Life expectancy, employment, and education showed positive linear associations with consumption, whereas inadequate water supply and sanitation were inversely associated. Municipality income was positively associated with the average consumption of psychoactive medicines, but those with a very high human development index for income showed more complex dynamics. Our results suggest that COVID-19 mortality was associated with psychotropic medicine consumption and indicate the need to address socioeconomic vulnerability as a key component of public health emergency responses.

PLoS ONEVol. 21(5)
Universidade Federal Fluminense (BR)
Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
Openalex Percentile: Top 5%
COVID-19 and Mental Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.